EIZO Corporation
Notice Regarding Revision of Numerical Targets in Medium-Term Management Plan
The revenue target for the fiscal year ending March 2027 was significantly revised downward from 100 billion yen to 85 billion yen, and operating income from 12 billion yen to 3.3 billion yen.
Key Figures
- Net Sales: 85 billion yen (150 billion yen below initial plan)
- Operating Income: 3.3 billion yen (8.7 billion yen below initial plan)
- ROE: 3.1% (4.9 points below initial plan)
AI要約
Overview of Numerical Target Revision
EIZO Corporation has revised its numerical targets for the fiscal year ending March 2027 (the final year of the 8th Medium-Term Management Plan), significantly lowering revenue from 100 billion yen to 85 billion yen and operating income from 12 billion yen to 3.3 billion yen. Operating margin is expected to decline from 12.0% to 3.9%, and ROE from 8.0% to 3.1%. This is due to prolonged sluggishness in the key European market, deterioration in hospital management in Japan, and rising geopolitical risks.
Background of the Revision and Future Policy
Assuming no sharp recovery in the European market, the B&P and Creative Work markets are expected to remain flat. The V&S market is anticipated to grow due to solid demand, while the healthcare market is expected to continue sluggish demand in Japan but recover overseas. Efforts will be made to control costs, keeping fixed costs at the level of the fiscal year ending March 2026. The fiscal year ending March 2027 is positioned as the 'year of recovery of earning power,' and a roadmap aiming for sustained ROE improvement will be presented in the next medium-term management plan starting from the fiscal year ending March 2028.
